Literature DB >> 12471590

Gammadelta T lymphocytosis associated with granulomatous disease in a patient with common variable immunodeficiency.

Jean-François Viallard1, Coralie Bloch-Michel, Olivier Caubet, Marie Parrens, Jeannette Texier-Maugein, Martine Neau-Cransac, Jean-Luc Taupin, Jean-François Moreau, Jean-Luc Pellegrin.   

Abstract

Common variable immunodeficiency (CVID) is a heterogeneous group of immunodeficiency syndromes that involves defective production of specific antibodies and decreased serum concentrations of > or =1 immunoglobulin isotype. We describe a patient with an atypical case of CVID who had extensive granulomatous lesions that were partially attributable to mycobacterial infection. In the peripheral blood, there was a massive increase in the number of double-negative CD3+ T cells that expressed the gammadelta T cell receptor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12471590     DOI: 10.1086/344469

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  4 in total

Review 1.  Granulomatous disease in common variable immunodeficiency.

Authors:  Yoshikazu Morimoto; John M Routes
Journal:  Curr Allergy Asthma Rep       Date:  2005-09       Impact factor: 4.919

2.  Inversion of the Vδ1 to Vδ2 γδ T cell ratio in CVID is not restored by IVIg and is associated with immune activation and exhaustion.

Authors:  Dominic Paquin-Proulx; Nathália Silveira Barsotti; Bianca A N Santos; Ana Karolina B B Marinho; Cristina M Kokron; Karina I Carvalho; Myrthes T Barros; Jorge Kalil; Douglas F Nixon; Esper G Kallas
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

3.  What Works When Treating Granulomatous Disease in Genetically Undefined CVID? A Systematic Review.

Authors:  Astrid C van Stigt; Willem A Dik; Lieke S J Kamphuis; Bas M Smits; Joris M van Montfrans; P Martin van Hagen; Virgil A S H Dalm; Hanna IJspeert
Journal:  Front Immunol       Date:  2020-12-17       Impact factor: 7.561

4.  T-cell activation discriminates subclasses of symptomatic primary humoral immunodeficiency diseases in adults.

Authors:  Marie-Quitterie Picat; Rodolphe Thiébaut; François Lifermann; Xavier Delbrel; Daniel Adoue; Linda Wittkop; Anne-Laure Fauchais; Patrick Rispal; Jean-François Moreau; Jean-François Viallard
Journal:  BMC Immunol       Date:  2014-03-12       Impact factor: 3.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.